• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PI3K/AKT 通路在 NT2D1 非精原细胞瘤细胞中被 HGF 激活,并在调节其恶性行为中发挥作用。

The PI3K/AKT Pathway Is Activated by HGF in NT2D1 Non-Seminoma Cells and Has a Role in the Modulation of Their Malignant Behavior.

机构信息

Section of Histology and Medical Embryology, Department of Anatomy, Histology, Forensic-Medicine and Orthopedics, "Sapienza" University of Rome, 00161 Rome, Italy.

Department of Surgery "Pietro Valdoni", "Sapienza" University of Rome, 00161 Rome, Italy.

出版信息

Int J Mol Sci. 2020 Nov 17;21(22):8669. doi: 10.3390/ijms21228669.

DOI:10.3390/ijms21228669
PMID:33212946
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7698414/
Abstract

Overactivation of the c-MET/HGF system is a feature of many cancers. We previously reported that type II testicular germ cell tumor (TGCT) cells express the c-MET receptor, forming non-seminomatous lesions that are more positive compared with seminomatous ones. Notably, we also demonstrated that NT2D1 non-seminomatous cells (derived from an embryonal carcinoma lesion) increase their proliferation, migration, and invasion in response to HGF. Herein, we report that HGF immunoreactivity is more evident in the microenvironment of embryonal carcinoma biopsies with respect to seminomatous ones, indicating a tumor-dependent modulation of the testicular niche. PI3K/AKT is one of the signaling pathways triggered by HGF through the c-MET activation cascade. Herein, we demonstrated that phospho-AKT increases in NT2D1 cells after HGF stimulation. Moreover, we found that this pathway is involved in HGF-dependent NT2D1 cell proliferation, migration, and invasion, since the co-administration of the PI3K inhibitor LY294002 together with HGF abrogates these responses. Notably, the inhibition of endogenous PI3K affects collective cell migration but does not influence proliferation or chemotactic activity. Surprisingly, LY294002 administered without the co-administration of HGF increases cell invasion at levels comparable to the HGF-administered samples. This paradoxical result highlights the role of the testicular microenvironment in the modulation of cellular responses and stimulates the study of the testicular secretome in cancer lesions.

摘要

c-MET/HGF 系统的过度激活是许多癌症的一个特征。我们之前报道过,Ⅱ型睾丸生殖细胞肿瘤(TGCT)细胞表达 c-MET 受体,形成非精原细胞瘤性病变,与精原细胞瘤性病变相比更为阳性。值得注意的是,我们还证明 NT2D1 非精原细胞瘤细胞(源自胚胎癌病变)在 HGF 的刺激下增加其增殖、迁移和侵袭。在此,我们报告 HGF 免疫反应性在胚胎癌活检的微环境中比精原细胞瘤更明显,表明肿瘤依赖性调节睾丸小生境。PI3K/AKT 是 HGF 通过 c-MET 激活级联触发的信号通路之一。在此,我们证明 NT2D1 细胞在 HGF 刺激后磷酸化 AKT 增加。此外,我们发现该途径参与 HGF 依赖性 NT2D1 细胞增殖、迁移和侵袭,因为共同给予 PI3K 抑制剂 LY294002 和 HGF 可消除这些反应。值得注意的是,内源性 PI3K 的抑制作用会影响细胞的集体迁移,但不会影响增殖或趋化活性。令人惊讶的是,没有与 HGF 共同给药而给予 LY294002 会增加细胞侵袭,达到与给予 HGF 的样本相当的水平。这一矛盾的结果突出了睾丸微环境在调节细胞反应中的作用,并刺激了对癌症病变中睾丸分泌组的研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01f4/7698414/184a47cf8c65/ijms-21-08669-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01f4/7698414/6da766d17ffd/ijms-21-08669-g001a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01f4/7698414/1009cd017b76/ijms-21-08669-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01f4/7698414/1a40580c070e/ijms-21-08669-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01f4/7698414/65b3a7f3ce13/ijms-21-08669-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01f4/7698414/323da0e7b4e5/ijms-21-08669-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01f4/7698414/5a26ea034508/ijms-21-08669-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01f4/7698414/7e856001282f/ijms-21-08669-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01f4/7698414/184a47cf8c65/ijms-21-08669-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01f4/7698414/6da766d17ffd/ijms-21-08669-g001a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01f4/7698414/1009cd017b76/ijms-21-08669-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01f4/7698414/1a40580c070e/ijms-21-08669-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01f4/7698414/65b3a7f3ce13/ijms-21-08669-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01f4/7698414/323da0e7b4e5/ijms-21-08669-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01f4/7698414/5a26ea034508/ijms-21-08669-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01f4/7698414/7e856001282f/ijms-21-08669-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01f4/7698414/184a47cf8c65/ijms-21-08669-g008.jpg

相似文献

1
The PI3K/AKT Pathway Is Activated by HGF in NT2D1 Non-Seminoma Cells and Has a Role in the Modulation of Their Malignant Behavior.PI3K/AKT 通路在 NT2D1 非精原细胞瘤细胞中被 HGF 激活,并在调节其恶性行为中发挥作用。
Int J Mol Sci. 2020 Nov 17;21(22):8669. doi: 10.3390/ijms21228669.
2
c-Src Recruitment is Involved in c-MET-Mediated Malignant Behaviour of NT2D1 Non-Seminoma Cells.c-Src 募集参与 c-MET 介导的 NT2D1 非精原细胞瘤细胞的恶性行为。
Int J Mol Sci. 2019 Jan 14;20(2):320. doi: 10.3390/ijms20020320.
3
ERK Signaling Pathway Is Constitutively Active in NT2D1 Non-Seminoma Cells and Its Inhibition Impairs Basal and HGF-Activated Cell Proliferation.ERK信号通路在NT2D1非精原细胞瘤细胞中持续激活,抑制该通路会损害基础及HGF激活的细胞增殖。
Biomedicines. 2023 Jul 4;11(7):1894. doi: 10.3390/biomedicines11071894.
4
Role of c-Met/phosphatidylinositol 3-kinase (PI3k)/Akt signaling in hepatocyte growth factor (HGF)-mediated lamellipodia formation, reactive oxygen species (ROS) generation, and motility of lung endothelial cells.c-Met/磷酸肌醇 3-激酶(PI3k)/Akt 信号通路在肝细胞生长因子(HGF)介导的肺内皮细胞片状伪足形成、活性氧(ROS)生成和运动中的作用。
J Biol Chem. 2014 May 9;289(19):13476-91. doi: 10.1074/jbc.M113.527556. Epub 2014 Mar 14.
5
MiR-206 inhibits HGF-induced epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via c-Met /PI3k/Akt/mTOR pathway.微小RNA-206通过c-Met/PI3k/Akt/mTOR信号通路抑制非小细胞肺癌中肝细胞生长因子诱导的上皮-间质转化和血管生成。
Oncotarget. 2016 Apr 5;7(14):18247-61. doi: 10.18632/oncotarget.7570.
6
Hepatocyte growth factor (HGF) upregulates heparanase expression via the PI3K/Akt/NF-κB signaling pathway for gastric cancer metastasis.肝细胞生长因子(HGF)通过PI3K/Akt/NF-κB信号通路上调乙酰肝素酶表达,促进胃癌转移。
Cancer Lett. 2015 May 28;361(1):57-66. doi: 10.1016/j.canlet.2015.02.043. Epub 2015 Feb 26.
7
CAF-derived HGF promotes cell proliferation and drug resistance by up-regulating the c-Met/PI3K/Akt and GRP78 signalling in ovarian cancer cells.癌相关成纤维细胞衍生的肝细胞生长因子通过上调卵巢癌细胞中的c-Met/PI3K/Akt和GRP78信号促进细胞增殖和耐药性。
Biosci Rep. 2017 Apr 10;37(2). doi: 10.1042/BSR20160470. Print 2017 Apr 28.
8
Norcantharidin combined with EGFR-TKIs overcomes HGF-induced resistance to EGFR-TKIs in EGFR mutant lung cancer cells via inhibition of Met/PI3k/Akt pathway.去甲斑蝥素联合表皮生长因子受体酪氨酸激酶抑制剂(EGFR-TKIs)通过抑制Met/PI3k/Akt信号通路克服了HGF诱导的EGFR突变肺癌细胞对EGFR-TKIs的耐药性。
Cancer Chemother Pharmacol. 2015 Aug;76(2):307-15. doi: 10.1007/s00280-015-2792-x. Epub 2015 Jun 11.
9
PHA665752 inhibits the HGF-stimulated migration and invasion of cells by blocking PI3K/AKT pathway in uveal melanoma.PHA665752 通过阻断 PI3K/AKT 通路抑制 HGF 刺激的葡萄膜黑素瘤细胞的迁移和侵袭。
Neoplasma. 2017;64(3):377-388. doi: 10.4149/neo_2017_308.
10
c-MET receptor as potential biomarker and target molecule for malignant testicular germ cell tumors.c-MET受体作为恶性睾丸生殖细胞肿瘤的潜在生物标志物和靶分子。
Oncotarget. 2018 Aug 7;9(61):31842-31860. doi: 10.18632/oncotarget.25867.

引用本文的文献

1
Oncofetal reprogramming in tumor development and progression: novel insights into cancer therapy.肿瘤发生发展中的癌胚重编程:癌症治疗的新见解
MedComm (2020). 2023 Dec 2;4(6):e427. doi: 10.1002/mco2.427. eCollection 2023 Dec.
2
Upregulated expression of miR-4443 and miR-4488 in drug resistant melanomas promotes migratory and invasive phenotypes through downregulation of intermediate filament nestin.miR-4443 和 miR-4488 在耐药性黑色素瘤中的表达上调通过下调中间丝巢蛋白促进迁移和侵袭表型。
J Exp Clin Cancer Res. 2023 Nov 27;42(1):317. doi: 10.1186/s13046-023-02878-9.
3
Case report: PIK3CA somatic mutation leading to Klippel Trenaunay Syndrome and multiple tumors.

本文引用的文献

1
PI3K inhibitors: review and new strategies.PI3K抑制剂:综述与新策略
Chem Sci. 2020 May 19;11(23):5855-5865. doi: 10.1039/d0sc01676d. eCollection 2020 Jun 21.
2
Response rate and local recurrence after concurrent immune checkpoint therapy and radiotherapy for non-small cell lung cancer and melanoma brain metastases.非小细胞肺癌和黑色素瘤脑转移患者同步免疫检查点治疗和放疗后的缓解率和局部复发率。
Cancer. 2020 Dec 15;126(24):5274-5282. doi: 10.1002/cncr.33196. Epub 2020 Sep 14.
3
The prognostic value of HGF-c-MET signaling pathway in Gastric Cancer: a study based on TCGA and GEO databases.
病例报告:PIK3CA体细胞突变导致克-特综合征及多发肿瘤。
Front Genet. 2023 Aug 17;14:1213283. doi: 10.3389/fgene.2023.1213283. eCollection 2023.
4
ERK Signaling Pathway Is Constitutively Active in NT2D1 Non-Seminoma Cells and Its Inhibition Impairs Basal and HGF-Activated Cell Proliferation.ERK信号通路在NT2D1非精原细胞瘤细胞中持续激活,抑制该通路会损害基础及HGF激活的细胞增殖。
Biomedicines. 2023 Jul 4;11(7):1894. doi: 10.3390/biomedicines11071894.
HGF-c-MET 信号通路在胃癌中的预后价值:基于 TCGA 和 GEO 数据库的研究。
Int J Med Sci. 2020 Jul 19;17(13):1946-1955. doi: 10.7150/ijms.44952. eCollection 2020.
4
Testicular cancer: Determinants of cisplatin sensitivity and novel therapeutic opportunities.睾丸癌:顺铂敏感性的决定因素和新的治疗机会。
Cancer Treat Rev. 2020 Aug;88:102054. doi: 10.1016/j.ctrv.2020.102054. Epub 2020 Jun 8.
5
Controversies in the management of clinical stage 1 testis cancer.临床I期睾丸癌治疗中的争议
Can Urol Assoc J. 2020 Nov;14(11):E537-E542. doi: 10.5489/cuaj.6722.
6
Cisplatin Resistance in Testicular Germ Cell Tumors: Current Challenges from Various Perspectives.睾丸生殖细胞肿瘤中的顺铂耐药性:多视角下的当前挑战
Cancers (Basel). 2020 Jun 17;12(6):1601. doi: 10.3390/cancers12061601.
7
Targeting the HGF/MET Axis in Cancer Therapy: Challenges in Resistance and Opportunities for Improvement.靶向HGF/MET轴在癌症治疗中的应用:耐药性挑战与改进机遇
Front Cell Dev Biol. 2020 May 6;8:152. doi: 10.3389/fcell.2020.00152. eCollection 2020.
8
Role of PI3K/AKT pathway in cancer: the framework of malignant behavior.PI3K/AKT 通路在癌症中的作用:恶性行为的框架。
Mol Biol Rep. 2020 Jun;47(6):4587-4629. doi: 10.1007/s11033-020-05435-1. Epub 2020 Apr 24.
9
B7-H3 Induces Ovarian Cancer Drugs Resistance Through An PI3K/AKT/BCL-2 Signaling Pathway.B7-H3通过PI3K/AKT/BCL-2信号通路诱导卵巢癌耐药。
Cancer Manag Res. 2019 Dec 3;11:10205-10214. doi: 10.2147/CMAR.S222224. eCollection 2019.
10
miRNA-302s may act as oncogenes in human testicular germ cell tumours.miRNA-302s 可能在人类睾丸生殖细胞肿瘤中作为癌基因发挥作用。
Sci Rep. 2019 Jun 24;9(1):9189. doi: 10.1038/s41598-019-45573-6.